REVIEW. Prognostic Scores for Predicting Recurrence in Patients with Differentiated Thyroid Cancer. Charoonsak Somboonporn. Abstract.
|
|
- Neal Hunter
- 6 years ago
- Views:
Transcription
1 DOI: Prgnstic Scres fr Predicting Recurrence in Differentiated Thyrid Cancer Cases REVIEW Prgnstic Scres fr Predicting Recurrence in Patients with Differentiated Thyrid Cancer Charnsak Smbnprn Abstract Backgrund: Differentiated thyrid cancer (DTC) is a cancer grup that shares mlecular and cellular rigin but shws different clinical curses and prgnses. Several prgnstic factrs have been reprted fr predicting recurrence fr individual patients. This literature review aimed t evaluate prgnstic scres fr predicting recurrence f DTC. Materials and Methds: A search f the MEDLINE database fr articles published until December 2015 was carried ut using the terms thyrid neplasms AND (recurrent OR persistent) AND (scre OR mdel OR nmgram). Studies were eligible fr review if they indicated the develpment f prgnstic scring mdels, derived frm a grup f independent prgnstic factrs, in predicting disease recurrence in DTC patients. Results: Of the 308 articles btained, five were eligible fr evaluatin. Tw scring mdels were develped fr DTC including bth papillary and fllicular carcinma, ne fr papillary carcinma, and the ther tw fr papillary micrcarcinma. The number f patients included in the scre develpment chrt ranged frm 59 t 1,669. The number f evaluated ptential prgnstic factrs ranged frm 4 t 25. Tumr-related factrs were the mst cmmn factrs included in the final scres, with cervical lymph nde metastases being the mst cmmn. Only tw studies shwed internal validatin f the derived scre. Cnclusins: There is a paucity f prgnstic scres fr predicting disease recurrence in patients with DTC, in particular fr fllicular thyrid carcinma. Several limitatins f the created scres were fund. Perfrmance f the scres has nt been adequately studied. Cmprehensive validatin in multiple chrts is recmmended befre widespread use. Keywrds: Thyrid neplasms - recurrence - prgnsis - prgnstic scres Asian Pac J Cancer Prev, 17 (5), Intrductin Thyrid cancer cmprises a grup f tumrs with different characteristics. Differentiated thyrid cancer (DTC) cmprises papillary carcinma and fllicular carcinma, including their variants. Mstly, DTC has an indlent clinical curse with lw mrtality. The 10-year survival rates fr papillary and fllicular thyrid cancer have been reprted t be 93-94% and 84-85%, respectively (Hundahl et al., 1998; Mazzaferri and Kls, 2001). Hwever, a mre aggressive disease with lw survival and high recurrence ccurs in sme patients. Althugh disease-specific mrtality is f great cncern, recurrence is anther imprtant utcme as a result f a lng-term clinical curse f the disease. Identifying patients f ptentially having high risk f recurrence helps individual management plan. A wide variety f individual prgnstic factrs fr DTC recurrence have been reprted in the literature (Haugen et al., 2016); hwever, using all f them is nt practical. Hence, prgnstic scring mdels have been develped t ease risk stratificatin in rutine clinical practice. The aim f this review was t identify and evaluate available prgnstic scres in predicting disease recurrence in patients with DTC. Materials and Methds Eligibility criteria fr selecting studies A review f previusly published articles explring prgnstic scres fr DTC recurrence was carried ut. A search f the MEDLINE database until December 2015 was dne using the terms thyrid neplasms AND (recurren* OR persisten*) AND (scr* OR mdel OR nmgram*) with language limitatin t articles published in English. After screening the titles and abstracts, as well as full text articles when needed, the eligible articles were identified fr data extractin. The eligibility criteria included studies identifying independent prgnstic factrs fr DTC recurrence using multivariate analysis and creating scring mdel frm these significant prgnstic factrs. Data extractin and presentatin Department f Radilgy, Faculty f Medicine, Khn Kaen University, Khn Kaen, Thailand *Fr crrespndence: charnsak. sm@gmail.cm Asian Pacific Jurnal f Cancer Preventin, Vl 17,
2 Charnsak Smbnprn These data were extracted and presented fr each study: first authr s name, publicatin year, cuntry f rigin, characters f study patients, recurrence rate, fllw-up perid, the number f patients in the scre develpment and validatin chrt (if presented), Table 1. Prgnstic Scres fr Differentiated Thyrid Cancer Recurrence 2370 Asian Pacific Jurnal f Cancer Preventin, Vl 17, 2016 the number f factrs included in the scring mdel, explred ptential prgnstic factrs, independent prgnstic factrs btained frm multivariate analysis, and perfrmance f the scre (if presented). Individual prgnstic factrs were categrized accrding t the First authr Welsch M Onitil AA Buffet C Niemeier LA Kim KM Publicatin year Cuntry Germany USA France USA Krea Study patients DTC DTC PMCA PMCA PTC Recurrence rate (%) Fllw-up perid, year (Mean + SD r mean) 9 ± ± * and 4.8** 8.3 Number f patients in the scre develpment chrt , Number f patients in the scre validatin chrt NA 595 NA 40 NA Number f prgnstic factrs included in the scring mdel Tumr factrs Tumr histlgy Tumr histpathlgic grading Tumr size Tumr fibrsis Psammma bdies Anatmic lcatin f primary tumr Superficial lcatin f primary tumr Multifcality Distance t resected margin f primary tumr Histlgic lymph nde metastases Preperative imaging lymph nde metastases Vascular invasin Infiltratin f surrunding tissue r ETE Tumr capsule invlvement Thyrid capsule invasin Infiltrative brder Psitive resectin margin Lymph nde status mrphlgy Lymph nde in PET scan Lymph nde in RAI scan Pulmnary metastases mrphlgy Pulmnary metastases in PET scan Pulmnary metastases in RAI scan Bne scan Bne metastases mrphlgy Bne metastases in PET scan Bne metastases in RAI scan Other rgan metastases mrphlgy Other rgan metastases in PET scan Other rgan metastases in RAI scan Distant metastases Patient factrs Age Gender Serum Tg level befre RAI treatment Serum Tg level 6 weeks after RAI treatment Current serum Tg level (at any time) Hashimt s thyriditis Treatment factrs BRAF V600E mutatin Type f thyrid surgery Pst-thyridectmy RAI treatment Initial cervical lymph nde surgery Initial diagnsis year DTC, differentiated thyrid cancer; PTC, papillary thyrid carcinma; PMCA, papillary micrcarcinma; PET, psitrn emissin tmgraphy; RAI, radiactive idine; Tg, thyrglbulin ; ETE, extrathyrid extensin; NA, nt applicable due t scre validatin nt perfrmed; *in aggressive grup, **in nn-aggressive grup; indicates prgnstic factrs that did nt shw statistically significant assciatin with recurrence; indicates prgnstic factrs that shwed statistically significant assciatin with recurrence; indicates prgnstic factrs selected int the prgnstic scre
3 DOI: Prgnstic Scres fr Predicting Recurrence in Differentiated Thyrid Cancer Cases Table 2. Prgnstic Factrs and Crrespnding Scre Pints in the Multiparameter Scring System (Welsch et al., 2007) Prgnstic factrs Characteristics Scre pints Gender Male 1 Female -1 Age Fr every year < Fr every year > Histlgy Papillary -1 Fllicular 1 Primary histpathlgic grading G1-2 G2 1 G3 2 G4 5 Primary lymph nde status (accrding t histlgic reprt) N metastases -1 Ipsilateral metastases 2 Cntralateral metastases 3 Tumr diameter Fr every mm < Fr every mm > Infiltratin f surrunding tissue N 0 Yes 5 Tumr capsule invlvement Yes -2 N 1 Thyrid capsule N cntact t capsule -2 Cntact t capsule 2 Extensin beynd capsule 4 Lymph nde status mrphlgy N metastases -1 Ipsilateral metastases 2 Cntralateral metastases 4 Lymph nde in PET scan N FDG uptake -2 Psitive FDG uptake 2 Lymph nde in RAI scan Psitive RAI uptake -1 N RAI uptake 2 Pulmnary metastases mrphlgy N metastases -1 One metastasis 3 2 metastases 5 Pulmnary metastases in PET scan N FDG uptake -2 Psitive FDG uptake 4 Pulmnary metastases in RAI scan Psitive RAI uptake -1 N RAI uptake 4 Bne scan Negative -1 Psitive 3 Bne metastases mrphlgy N metastases 0 One metastasis 5 2 metastases 7 Bne metastases in PET scan N FDG uptake -2 Psitive FDG uptake 4 Bne metastases in RAI scan Psitive RAI uptake -1 N RAI uptake 4 Other rgan metastases mrphlgy N metastases -1 One metastasis 2 2 metastases 3 Other rgan metastases in PET scan N FDG uptake -1 Psitive FDG uptake 1 Other rgan metastases in RAI scan Psitive RAI uptake -1 N RAI uptake 2 Serum Tg level befre RAI treatment (ng/ml) < >100 4 Serum Tg level 6 weeks after RAI treatment (ng/ml) < >100 6 Serum Tg level at any time f presentatin (ng/ml) < >100 7 PET, psitrn emissin tmgraphy; RAI, radiactive idine; Tg, thyrglbulin Asian Pacific Jurnal f Cancer Preventin, Vl 17,
4 Charnsak Smbnprn cncept f subject-based classificatin as tumr-related factrs, patient-related factrs, and treatment-related factrs (Gspdarwicz et al., 2006). Results Of the 308 articles screened, five studies were identified and included fr review (Welsch et al., 2007; Onitil et al., 2009; Buffet et al., 2012; Niemeier et al., 2012; Kim et al., 2013). All are retrspective chrt study. The studies were published during 2007 t Tw studies were frm the United States (Onitil et al., 2009; Niemeier et al., 2012), tw frm Eurpe (Welsch et al., 2007; Buffet et al., 2012), and ne frm Asia (Kim et al., 2013). The study size f the scre develpment chrt ranged frm 59 t 1,669 patients, and in ttal cnsisted f 3,106 participants. The study patients were DTC (including bth papillary and fllicular carcinma) in tw studies (Welsch et al., 2007; Onitil et al., 2009), while the remaining three studies included exclusively patients with papillary carcinma (Buffet et al., 2012; Niemeier et al., 2012; Kim et al., 2013); tw f them (Buffet et al., 2012; Niemeier et al., 2012) fcused nly patients with primary tumr size f 1 cm, the s-called papillary micrcarcinma (PMCA). Table 1 represents a summary f the studies included in this review. Prgnstic factrs that were fund withut and with statistically significant assciatin with disease recurrence were indicated as pen circle and clsed circle, respectively. In additin, factrs that were selected int the prgnstic scring mdels were indicated as square. Finally, the number f prgnstic factrs included in the scring mdels ranged frm 4 t 25. Mst f the independent prgnstic factrs were tumr pathlgic factrs, such as cervical lymph nde metastases, tumr size, multifcality, and extrathyrid extensin (ETE). Age and gender were patient factrs that were fund significantly assciated with recurrence in tw f the fur studies examining these factrs. In ne study, BRAF mutatin was fund t be a prgnstic factr fr recurrence in PMCA patients. N treatment factrs were fund t be significantly assciated with recurrence utcme. In three studies, prgnstic scres were develped frm evaluated prgnstic factrs that shwed statistically significant assciatin with recurrence utcme (Buffet et al., 2012; Niemeier et al., 2012; Kim et al., 2013). Hwever, the ther tw studies had variatin in selecting factrs int the final scring scheme. The prpsed scre by Welsch et al. in 2007 adpted all ptential prgnstic factrs int the scring scheme, even thugh sme f them were nt statistically significant. In the study by Onitil et al. in 2009, althugh shwing n significant assciatin with recurrence, tumr histlgy was frced int the mdel, while distant metastasis, an independent factr, was excluded frm the mdel. Applicatin f these five prgnstic scring systems was described as fllws 1. Multiparameter scring system (Welsch et al., 2007): This scre was calculated by additin r subtractin 2372 Asian Pacific Jurnal f Cancer Preventin, Vl 17, 2016 f the scre pints crrespnding t each prgnstic factr (Table 2). Factrs that were nt available were scred with the value zer. Five categries f prbability f disease recurrence were estimated accrding t the crrespnding cut-ff pints: 3.9% fr scres 10; 14.1% fr scres -10 t 0; 46.2% fr scres 0 t 10; 66.7% fr scres 10 t 20; and 100% fr scres > Alternative quantitative t the TNM scring system (Onitil et al., 2009): Prgnstic scre = sum f the fllwings: Histpathlgy = 1 if nt papillary thyrid carcinma, therwise 0; Age = 4 if 45 years, therwise 0; Reginal lymph nde metastases = 4, therwise 0; Primary tumr size = 6 if > 4 cm limited t thyrid gland r any tumr with ETE, therwise 0. Three categries f prbability f 10-year disease-free survival (DFS) were estimated accrding t the crrespnding cut-ff pints: 95% fr scres 0 t 5; 70% fr scres 6 t 10; and 45% fr scres 11 t Scring system fr PMCA (Buffet et al., 2009): Prgnstic scre = sum f the fllwings: Gender: female = 0, male = 1; Multifcality: absent = 0, present = 1; Lymph nde metastases: absent = 0, present = 3. Three categries f 10-year recurrence prbability (with 95% CI) were estimated accrding t the crrespnding cut-ff pints: 2.7% (1.3 t 4.1%) fr scres 0 t 2; 24% (13.7 t 34.3%) fr scres 3 t 4; and 42.6% (12.7 t 72.5%) fr scre Cmbined mlecular-pathlgical scre fr PMCA (Niemeier et al., 2012): Prgnstic scre = 1 if tumr in superficial lcatin f thyrid gland + 1 if BRAF psitive + 1 if multifcality present + 1 if extensive fibrsis in primary tumr present. Three categries f recurrence risk were estimated accrding t the crrespnding cutff pints: 0% fr scres 0 t 2; 20% fr scre 3; and 60% fr scre Clinical prgnstic index f University f Ynsei (Kim et al., 2013): Prgnstic scre = (0.03 x age in years) if male gender if ETE present if preperative lymph nde metastases present. Fur categries f 10-year DFS were estimated accrding t the crrespnding cut-ff pints: 95.6% fr scres <1.50; 94.5% fr scres 1.50 t 2.29; 85.0% fr scres 2.30 t 3.29; and 27.3% fr scres Discussin Since cmbined multiple prgnstic factrs perfrm better in predicting the utcme than individual variable des, all ptential factrs can be evaluated and the factrs that have the mst degree f assciatin with the utcme are identified. Weight f assciatin f these factrs can be used t create a summed prgnstic scre fr predicting the utcme. This review identified five studies attempting t cnstruct the risk predictin mdel fr disease recurrence in patients with DTC. The review fund diversity amng patient characteristics, variability in definitin f utcme and event rate, and variability in the evaluated prgnstic factrs and their definitins in each study. Of all five prgnstic scres, tw were develped in DTC patients, but three scres were studied in purely papillary thyrid
5 carcinma; tw f these fcused nly n PMCA patients. Nne was carried ut in patients with purely fllicular thyrid carcinma. In fact, the ttal number f patients diagnsed with fllicular carcinma included in the tw studies (Welsch et al., 2007; Onitil et al., 2009) was nly 225. Cautin is needed in applying these scres fr predicting utcme in affected patients. Definitin f recurrence utcme varied acrss the studies. The prgnstic scre f Welsch et al. reprted utcme as recurrence rate, while the scre f Kim et al. reprted it as disease-free survival. Hwever, the definitin f recurrence in bth studies was nt clearly defined. Onitil et al. reprted utcme as disease-free survival defined as the time t first recurrence; hwever, the definitin f recurrence was nt clearly defined. Buffet et al. reprted utcme as time t recurrence and clearly defined the definitin f recurrence, based n cytlgical r histlgical analysis, 131 I uptake in the lesin, and predetermined serum thyrglbulin (Tg) level. Niemeier et al. (2012) reprted utcme as recurrence rate and defined recurrence based n serum Tg measurements, neck ultrasngraphy, and clinical examinatin. The candidate prgnstic factrs included fr scre develpment varied widely amng studies. The majrity f them were tumr factrs, such as tumr histlgy, grading, tumr size, ETE, r cervical lymph nde metastases. Patient factrs were als evaluated, including age, gender, serum Tg level at varius time pints, and BRAF mutatin. Only a few treatment factrs were studied, such as type f thyridectmy and 131 I treatment. Amng all studies, mst f the independent prgnstic factrs were tumr pathlgic factrs and they were in accrdance with thse previusly identified in the literature, such as cervical lymph nde metastases (Schneider, et al., 2013; Lee et al., 2014), tumr size (It et al., 2012), multifcality (Qu et al., 2014), and extrathyrid extensin (Kim et al., 2014). This was als the case fr patient factrs, such as age and gender (Kim et al., 2014), and pstperative serum Tg level (Hasbek et al., 2014). BRAF mutatin included in the cmbined mlecular-pathlgical scre fr PMCA (Niemeier et al., 2012) has recently been reprted as a new and prmising prgnstic factrs related t tumr aggressiveness and high recurrent utcme (Kim et al., 2012; Fernandez et al., 2013; Xing et al., 2015). It shuld be nted that althugh nne f treatment factrs were fund t be significantly assciated with recurrence, nly tw studies included factrs f this dmain in their scre develpment chrts (Onitil et al., 2009; Buffet et al., 2012). Mst f the prgnstic scres attributed t nly 3 r 4 high-impact predictrs, which are easy t use, and are therefre practical in rutine clinical use (Onitil et al., 2009; Buffet et al., 2012; Niemeier et al., 2012; Kim et al., 2013). The prgnstic scre which accunted fr several predictrs as the multiparameter scring system seems nt easy t use, althugh the authrs claimed that nly the available predictrs culd be used t calculate the summed scre fr individual patient (Welsch et al., 2007). In additin, the scring mdels, in which the ttal scre was calculated frm the pint scres that were integers, wuld likely ease the use f the scres in the real-wrld DOI: Prgnstic Scres fr Predicting Recurrence in Differentiated Thyrid Cancer Cases clinical practice (Onitil et al., 2009; Buffet et al., 2012; Niemeier et al., 2012). The sample size and the number f utcme events are crucial issues fr prgnstic studies because they affect the regressin mdel assumptin. Nrmally, the mdels require an adequate number f utcme events fr each predictr. The rule f thumb dictates that at least 10 utcme events shuld be btained fr ne independent prgnstic factr (Guyatt, 2006). All studies in this review cnsisted f relatively lw recurrent rates, ranging frm % (r 6-68 events), likely due t shrt fllw-up perid, with the mean f nly years. This raised the cncern as t whether r nt these studies had adequate statistical pwer (Guuatt, 2006), particularly in the study explring a large number f prgnstic factrs (Welsch et al., 2007). Gd mdel perfrmance is imprtant fr widespread clinical applicatin f the scre. Variety in reprting scre perfrmance was bserved, such as percent f true r false classificatin f the utcme (Welsch et al., 2007), % sensitivity and % specificity (Niemeier et al., 2012), r prprtin f variant explained (Kim et al., 2013). The remaining tw studies reprted n infrmatin abut mdel perfrmance (Onitil et al., 2009; Buffet et al., 2012). N studies reprted scre perfrmance in terms f discriminatin ability f the scre, as measured by cncrdance C-index, and the scre calibratin (Pencina and D Agstin, 2004). Internal and external validatin f the derived scre is anther aspect in assessing prgnstic scre utilizatin. Tw studies reprted results f internal validatin f their prgnstic scres, in 595 patients in the study f Onitil et al. and 40 patients in the study f Niemeier et al., respectively. Nne f the evaluated scres perfrmed external validatin. Therefre, further studies shuld be carried ut by perfrming external validatin f these available scres in a different patient setting with an adequate number f sample size, such as a least 100 participants (Verguwe et al., 2005). There are sme limitatins f the review. Rbust cnclusin cannt be made regarding the prgnstic scre fr predicting DTC recurrence due t varying definitins f utcmes and incnsistent use f prgnstic factrs. Since searching f articles was nly dne in MEDLINE database, there is a pssibility that sme eligible studies indexed nly in ther databases may be missed. Language bias may be present because the search strategy was limited t article published in English. In cnclusin, there is a paucity f data n prgnstic scres fr predicting disease recurrence in patients with DTC. Several limitatins f the prpsed scres were fund. Perfrmance was nt adequately studied. Further studies with cmprehensive internal and external validatin in multiple chrts are recmmended befre widespread use. Acknwledgements This review was supprted by research fund frm the Ryal Glden Jubilee Ph.D. schlarship frm the Thailand Research Fund and the Faculty f Medicine, Khn Kaen Asian Pacific Jurnal f Cancer Preventin, Vl 17,
6 Charnsak Smbnprn University, Thailand. References Buffet C, Glmard JL, Hang C, et al (2012). Scring system fr predicting recurrences in patients with papillary thyrid micrcarcinma. Eur J Endcrinl, 167, Fernandez IJ, Piccin O, Sciascia S, et al (2013). Clinical significance f BRAF mutatin in thyrid papillary cancer. Otlaryng Head and Neck Surg, 148, Gspdarwicz MK, O Sullivan B, Kh ES (2006). Prgnstic factrs: principles and applicatins. In: Prgnstic factrs in cancer. 3 rd ed, Eds Gspdarwicz MK, O Sullivan B, Sbin LH. Jhn Wiley & Sns, New Jersey, Guyatt G (2006). Determining prgnsis and creating clinical decisin rules. In Clinical epidemilgy: hw t d clinical practice research.3rd ed, Eds Haynes RB, Sackett DL, Guyatt G, et al. Lippinctt Williams & Wilkins, Philadelphia, Hasbek Z, Turgut B, Kilicli F, Altuntas EE, Yucel B (2014). Imprtance f pstperative stimulated Tg level at the time f 131I ablatin therapy fr differentiated thyrid cancer. Asian Pac J Cancer Prev, 15, Haugen BR, Alexander EK, Bible KC, et al (2016) American Thyrid Assciatin management guidelines fr adult patients with thyrid ndules and differentiated thyrid cancer. Thyrid, 26, Hundahl SA, Flemming ID, Fremgen AM, Menck HR (1998). A Natinal Cancer Data Base reprt n 53,856 cases f thyrid carcinma treated in the U.S., Cancer, 83, It Y, Kud T, Kihara M, et al (2012). Prgnsis f lw-risk papillary thyrid carcinma patients: its relatinship with the size f primary tumrs. Endcr J, 59, Kim SJ, Lee KE, Myng JP, et al (2012). BRAF V600E mutatin is assciated with tumr aggressiveness in papillary thyrid cancer. Wrld J Surg, 36, Kim KM, Park JB, Bae KS, et al (2013). Clinical prgnstic index fr recurrence f papillary thyrid carcinma including intraperative findings. Endcr J, 60, Kim WY, Kim HY, Sn GS, Bae JW, Lee JB (2014). Clinicpathlgical, immunhistchemical factrs and recurrence assciated with extrathyridal extensin in papillary thyrid micrcarcinma. J Cancer Res Ther, 10, Lee J, Sng Y, Sh EY (2014). Prgnstic significance f the number f metastatic lymph ndes t stratify the risk f recurrence. Wrld J Surg, 38, Mazzaferri EL, Kls RT (2001). Current appraches t primary therapy f papillary and fllicular thyrid cancer. J Clin Endcrinl Metab, 86, Niemeier LA, Kuffner Akatsu H, Sng C, et al (2012). A cmbined mlecular-pathlgic scre imprves risk stratificatin f thyrid papillary micrcarcinma. Cancer, 118, Onitil AA, Engel JM, Lundgren CI, et al (2009). Simplifying the TNM system fr clinical use in differentiated thyrid cancer. J Clin Oncl, 27, Pencina MJ, D Agstin RB (2004). Overall C as a measure f discriminatin in survival analysis: mdel specific ppulatin value and cnfidence interval estimatin. Stat Med, 23, Qu N, Zhang L, Ji QH, et al (2014). Number f tumr fci predicts prgnsis in papillary thyrid cancer. BMC Cancer, 14, 914. Schneider DF, Mazeh H, Chen H, Sippel RS (2013). Lymph nde rati predicts recurrence in papillary thyrid cancer. Onclgist, 18, Verguwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD (2005). Substantial effective sample sizes were required fr external validatin studies f predictive lgistic regressin mdels, J Clin Epidemil, 58, Welsch M, Abeln M, Zaplatnikv K, et al (2007). Multiparameter scring system fr the prgnsis f differentiated thyrid cancer. Nuklearmedizin, 46, Xing M, AlzahraniAS, Carsn KA, et al (2015). Assciatin between BRAF V600E mutatin and recurrence f papillary thyrid cancer. J Clin Oncl, 33, ` Newly diagnsed withut treatment 2374 Asian Pacific Jurnal f Cancer Preventin, Vl 17, 2016
Data Fusion for Predicting Breast Cancer Survival
Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current
More informationVolume Measurement at CT
Vlume Measurement at CT Staging and Assessment f Respnse with Quantitative CT Lawrence Schwartz, MD Department f Radilgy Clumbia University Cllege f Physicians and Surgens LSCHWARTZ@COLUMBIA.EDU Recmmendatins
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More informationChapter 6: Impact Indicators
Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the
More informationNonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer
Nnclinical factrs assciated with premature terminatin f adjuvant chemtherapy fr stage I-III breast cancer Xia-Cheng Wu, Trevr Thmpsn, Meichin Hsieh, Meijia Zhu, Patricia Andrews, Michelle Lch, Timthy Styles,
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationReligious Beliefs, Knowledge about Science and Attitudes Towards Medical Genetics. Nick Allum, Elissa Sibley, Patrick Sturgis & Paul Stoneman
Religius Beliefs, Knwledge abut Science and Attitudes Twards Medical Genetics Nick Allum, Elissa Sibley, Patrick Sturgis & Paul Stneman Backgrund: medical genetics Genetics in medical research is ne f
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationA foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:
RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationAnnual Assembly Abstract Review Process
Annual Assembly Abstract Review Prcess AAHPM and HPNA cllabrate t review and select abstracts fr Annual Assembly. The cmmittees meet prir t the calls t review and update the Assembly bjectives (Planning
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationStudy Design Open, three arm-stratified, non-randomized, prospective, multicentric study
PONS Study Synpsis Title f the Study Subtype-Stratified Fllw-up Care Study f Breast Cancer Patients with Cmbined In Vitr and In Viv Diagnstics Plus Early Target-Oriented Interventin Gals Imprve and individualize
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationThyroglobulin levels in serum and saliva of patients with differentiated thyroid carcinoma
Pre, Indian Acad. Sci., Vl. 87 B (Experimental Bilgy-J), N.7, July 1978. pp. 169-1". @ printed in India Thyrglbulin levels in serum and saliva f patients with differentiated thyrid carcinma D SHAH, S DANDEKAR
More informationField Epidemiology Training Program
Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case
More informationPET FORM Planning and Evaluation Tracking ( Assessment Period)
Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationInternational Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1
Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More information2. How are screening and diagnostic mammograms different?
Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationCnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level
More informationTASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE
Sunday 19 July, 2015 TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE SIX STRATEGIC pririties have tday (Sunday) been recmmended by the Independent Cancer Taskfrce t help
More informationHealth Science Ch. 16 Cancer Lecture Outline
Cancer Leading cause f disease-related death amng peple under age 75 Secnd leading cause f death Evidence supprts that mst cancers culd be prevented by simple lifestyle changes Tbacc is respnsible fr abut
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated
More informationLTCH QUALITY REPORTING PROGRAM
4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04
More informationSUICIDE AND MENTAL ILLNESS IN SINGAPORE
Vl. 15, N. 3. SINGAPORE MEDICAL JOURNAL 191 September, 1974. SUICIDE AND MENTAL ILLNESS IN SINGAPORE By W. F. Tsi and B. H. Chia SYNOPSIS This is a study f 112 cases f suicides wh had a past histry f being
More informationStructured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information
Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in
More informationCHAPTER 2. HEALTH SERVICES
CHAPTER 2. HEALTH SERVICES 2.1 Treatment f substance use disrders within health services Thmas F Babr and Kerstin Stenius Overview Since the end f the Secnd Wrld War there has been a cnsistent grwth f
More informationService Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin
Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)
More informationMedical Policy Title: HDC & Autologous ARBenefits Approval: 02/08/2012
Medical Plicy Title: HDC & Autlgus ARBenefits Apprval: 02/08/2012 Stem&/r Prgenitr Cell Supprt, Germ Cell Tumrs Effective Date: 01/01/2013 Dcument: ARB0416:01 Revisin Date: 10/24/2012 Cde(s): 38230, Bne
More informationImproving Surveillance and Monitoring of Self-harm in Irish Prisons
HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June
More informationWCPT awards programme 2015
WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.
More informationSeeking and Appraising Evidence
EWMA Educatinal Develpment Prgramme Curriculum Develpment Prject Educatin Mdule: Seeking and Appraising Evidence Latest review: August 2012 Educatin Mdule: Seeking and Appraising Evidence ABOUT THE EWMA
More informationReliability and Validity Plan 2017
Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationDrug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)
Drug Class Review: Lng-acting muscarinic antagnists (LAMAs) fr treatment f chrnic bstructive pulmnary disease (COPD) Cmprehensive Research Plan: Pharmacepidemilgy Unit April 10 th, 2014 ODPRN Drug Class
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationCancer of Unknown Primary (CUP) Pathways and Guidelines (v 2) London Cancer. April 2017
Cancer f Unknwn Primary (CUP) Pathways and Guidelines (v 2) Lndn Cancer April 2017 The fllwing pathways and guidelines dcument has been cmpiled by the Lndn Cancer CUP technical subgrup and agreed by the
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationdetailed in Ward and Lockhead (1970), is only summarized here.
Respnse system prcesses in abslute judgment* LAWRENCE M. WARDt and G. R. LOCKHEAD Duke University, Durham, Nrth Carlina 2778 Cnsistent relatinships are fund between Ss' abslute judgments f the value f
More informationSession78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students
Sessin78-P.dc Cllege Adjustment And Sense Of Belnging Of First-Year Students: A Cmparisn Of Learning Cmmunity And Traditinal Students Jennifer Ann Mrrw, Ph.D. Assistant Prfessr Old Dminin University Department
More informationSUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY
EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY Sme 50% f cancers that affect wmen are lcated in the breast r in the genital rgans. Gynaeclgical
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationctdna-guided Change of Therapy Improves Quality of Life of a Lung Cancer Patient
CASE STUDY ctdna-guided Change f Therapy Imprves Quality f Life f a Lung Cancer Patient Quick Summary Tripti Vasudev*, aged 61 years, was diagnsed with NSCLC. Genetic analysis revealed the presence f an
More informationDiabetologia 9 Springer-Verlag 1983
Diabetlgia (1983) 24:336-341 Diabetlgia 9 Springer-Verlag 1983 Diabetes Mrtality: New Light n an Underestimated Public Health Prblem J. H. Fuller 1, J. Elfrd*, P. Gldblatt 2 and A. M. Adelstein 3 I Department
More informationTRANSPLANTATION AND CLINICAL IMMUNOLOGY. Proceedings of the Twenty-Second International Course, Lyon, May 1990
-----.---.----~ Reprinted frm: TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII Multiple Transplants Prceedings f the Twenty-Secnd Internatinal Curse, Lyn, 2-23 May 99 This publicatin was made pssible
More informationEchocardiography Diagnostic Accuracy
Echcardigraphy Diagnstic Accuracy Measure Descriptin: The prprtin f ptentially preventable and clinically imprtant inaccurate diagnses amng cngenital heart surgical patients. Numeratr Number f cngenital
More informationSpecifically, on page 12 of the current evicore draft, we find the statement:
Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit
More informationNeurological outcome from conservative or surgical treatment of cervical spinal cord injured patients
1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,
More informationRECURRENCE OF THYMOMA: ANALYSIS OF CLINICOPATHOLOGIC FEATURES, TREATMENT, AND OUTCOME
RCURRNC F THYMMA: ANALYSIS F CLINICPATHLGIC FATURS, TRATMNT, AND UTCM nric Ruffini, MD a Maurizi Mancus, MD a Albert liar, MD a Caterina Casadi, MD a Antni Cavall, MD a Rbert Cianci, MD a Pier Luigi Filss,
More informationThis information shows what new challenges are likely to require prevention efforts moving forward.
Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationTraining module 1: Summary
Draft (Step 2) guideline ICH E9(R1) Estimands and Sensitivity Analysis in Clinical Trials Training mdule 1: Summary Addendum t ICH E9 Statistical Principles fr Clinical Trials ICH E9(R1) Expert Wrking
More informationFOUNDATIONS OF DECISION-MAKING...
Table f Cntents FOUNDATIONS OF DECISION-MAKING... Errr! Bkmark nt Describe the decisin-making prcess pp.62-66... Errr! Bkmark nt Explain the three appraches managers can use t make decisins pp.67-70 Errr!
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationCampus Climate Survey
Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed
More informationCarcinoma of the esophagus
Carcinma f the esphagus Prgnstic significance f histlgic type Previus investigatrs have reprted that in patients with esphageal carcinma tumr cell type affects prgnsis. A retrspective analysis f 258 patients,
More informationNPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationAdhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy*
FERTILITY AND STERILITY Cpyright 99 The American Fertility Sciety Vl., N., May 99 Printed n acid-free paper in U.S.A. Adhesin frmatin after laparscpic surgery in tubal pregnancy: a randmized trial versus
More informationA Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013
A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the
More informationSuccess Criteria: Extend your thinking:
Discussin Directr Yur jb is t invlve thers in cnversatin abut the text by getting them t think and talk abut the BIG IDEAS in the chapter/ sectin they have just read. Cmpse 5 questins that yu want t discuss
More informationUNIT 2: mapping bananas
Oxfam Educatin www.xfam.rg.uk/educatin UNIT 2: mapping bananas Age range: 7-11 years Outline Learners will investigate sme f the cuntries where the bananas we eat in the UK are grwn. They will first lcate
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:
More informationCognitive enhancers for the treatment of Alzheimer s disease
Cmprehensive Research Plan: Cgnitive enhancers fr the treatment f Alzheimer s disease Pharmacepidemilgy Unit February 13 th, 2015 30 Bnd Street, Trnt ON, M5B 1W8 www.dprn.ca inf@dprn.ca 2 ODPRN Drug Class
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More information2018 Medical Association Poster Symposium Guidelines
2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the
More informationRefining Blood Collection Techniques to Improve Animal Welfare and Sample Quality
Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationDIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University of Toledo
The Psychlgical Recrd, 1999, 49, 211-220 DIRECTED FORGETIING: SHORT-TERM MEMORY OR CONDITIONED RESPONSE? WENDY S. MILLER and HARVARD L. ARMUS The University f Tled Previus researchers have interpreted
More informationPsychological Review
Psychlgical Review VOLUME 88 NUMBER 2 MARCH 1981 Jeren G. W. Raaijmakers University f Nijmegcn Nijmegen, The Netherlands Search f Assciative Memry Richard M. Shiffrin Indiana University A general thery
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationGUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH
GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationFTD RESEARCH: The Value of Studies and Opportunities for Involvement
FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver
More informationJapanese Rice Producers' Shift from High Yield to High Palatability and Quality -Characteristics of Highly Palatable Rice-
Jurnal f Develpments in Sustainable Agriculture 5: 96-1 (21) Japanese Rice Prducers' Shift frm High Yield t High Palatability and Quality -Characteristics f Highly Palatable Rice- Yuji Nitta* Cllege f
More informationAccounting Assessment Report
Accunting 2014-2015 Assessment Reprt 1. Please give a brief verview f the assessment data yu cllected this year. This can be in any frm yu feel is apprpriate, such as a table, a shrt narrative f results,
More informationUniversity of Rochester Course Evaluation Project. Ronald D. Rogge. Associate Professor. Ista Zahn. Doctoral Candidate
University f Rchester Curse Evaluatin Prject Rnald D. Rgge Assciate Prfessr Ista Zahn Dctral Candidate Department f Clinical & Scial Sciences in Psychlgy 2 Prject Impetus The current nline administratin
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationStrategic Plan Publication No: EO-SP
Strategic Plan 2017-2019 Publicatin N: EO-SP-170223 +61 2 9036 5002 www.pcg.rg.au pcg.ffice@sydney.edu.au This dcument was prepared by the PCG Executive Office PCG Publicatin number: EO-SP-170223 Psych-nclgy
More informationNational Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers
Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More information